CAS 83799-24-0
:Fexofenadin
- 2-(4-[1-Hydroxy-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butyl]-phenyl)-2-methyl-propionic acid
- 2-(4-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]phenyl)-2-methylpropanoic acid
- 2-[4-(1-Hydroxy-4-{4-[Hydroxy(Diphenyl)Methyl]Piperidin-1-Yl}Butyl)Phenyl]-2-Methylpropanoic Acid
- 4-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethylbenzeneacetic acid
- 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylphenylacetic acid
- Benzeneacetic acid, 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-
- Carboxyterfenadine
- Fexet
- Mdl 16455
- Telfast 120
- Terfenadine acid metabolite
- Terfenadine carboxylate
- Weitere Synonyme anzeigen
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Ref: 54-BUP15700
5mgNachfragen10mgNachfragen25mgNachfragen50mgNachfragen100mgNachfragen500mgNachfragenFexofenadine
CAS:Formel:C32H39NO4Reinheit:≥ 98.0%Farbe und Form:White to beige powderMolekulargewicht:501.66Fexofenadine
CAS:Kontrolliertes ProduktApplications The active metabolite of Terfenadine (T114500), a H1-histamine receptor antagonist.
References Garteiz, D.A., et al.: Arzneim.-Forsch., 32, 1185 (1982), Rampe, D., et al.: Mol. Pharmacol., 44, 1240 (1993), Obradovic, T., et al.: Pharm. Res., 24, 318 (2007),Formel:C32H39NO4Farbe und Form:NeatMolekulargewicht:501.662-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid
CAS:Formel:C32H39NO4Reinheit:95%Molekulargewicht:501.66Fexofenadine
CAS:Fexofenadine, a non-sedating antihistamine, treats allergies like hay fever and urticaria.Formel:C32H39NO4Reinheit:99.35%Farbe und Form:White To Off-White SolidMolekulargewicht:501.6564Fexofenadine
CAS:Fexofenadine is a selective histamine H1 receptor antagonist that has been shown to be effective in the treatment of allergic rhinitis. It is well tolerated and does not have any significant drug interactions. Fexofenadine is metabolized by cytochrome P450 (CYP) enzymes and undergoes extensive first-pass metabolism. This means that it should not interact with CYP inhibitors such as ketoconazole or cimetidine, but may increase the effects of CYP inducers such as phenobarbital or rifampin. Fexofenadine has been shown to inhibit the activity of human multidrug resistance protein 1 (MDR1) and P-glycoprotein (P-gp).
Reinheit:Min. 95 Area-%Farbe und Form:White Off-White PowderMolekulargewicht:501.66 g/mol








